Medical Device Contract Manufacturing Market Size, Share, Regional Growth, 2026-2034

Market OverviewAccording to fortune business insights, The global medical device contract manufacturing market size was valued at USD 87.43 billion in 2025. The market is projected to grow from USD 98.38 billion in 2026 to USD 252.95 billion by 2034, exhibiting a CAGR of 12.53% during the forecast period. North America dominated the medical device contract manufacturing market with a market share of 38% in 2025.This analysis highlights the increasing reliance on specialized manufacturing partners with expertise in precision engineering, quality assurance, and regulatory compliance. The market supports a wide range of medical devices, from low-risk consumables to highly complex implantable systems. This trend indicates strong demand driven by innovation in medical technology, growing healthcare needs, and the need for scalable manufacturing solutions that ensure consistency, cost efficiency, and compliance with global quality standards.

Major Players Profiled in the Market Report:

• Jabil Inc. (Florida, U.S.)

• Thermo Fisher Scientific Inc. (Massachusetts, U.S.)

• Integer Holdings Corporation (Texas, U.S.)

• Flex Ltd. (Texas, U.S.)

• Sanmina Corporation (California, U.S.)

• Phillips-Medisize (Wisconsin, U.S.)

• Plexus Corp. (Wisconsin, U.S.)

• Viant (Massachusetts, U.S.)

• West Pharmaceutical Services, Inc. (Pennsylvania, U.S.)

• Mack (Vermont, U.S.)

• Cirtec (Minnesota, U.S.)

• Coghlin Companies, Inc. (Massachusetts, U.S.)

SegmentsStrong Outsourcing for Moderately Complex Devices to Propel Class II Segment GrowthBased on product type, the market is divided into Class I, Class II, and Class III medical devices. The Class II segment holds the largest market share and dominates the market, representing nearly 44% of the share owing to strong outsourcing demand for diagnostic equipment, infusion systems, and monitoring devices that require greater regulatory oversight and performance validation.

High Demand for End-to-End Capabilities to Drive Device Manufacturing Segment ExpansionBy service type, the market is categorized into device manufacturing, accessories manufacturing, packaging & labeling, and others. The device manufacturing segment is leading the market as there is high demand for contract manufacturers with end-to-end capabilities, from assembly to final testing, allowing OEMs to reduce capital investment and speed commercialization.

Focus on Core Competencies to Drive OEM Segment DominanceBased on end user, the market is segmented into Original Equipment Manufacturers (OEMs), pharmaceutical and biopharmaceutical companies, and others. The OEM segment holds the largest market share, as these companies increasingly outsource manufacturing to focus on product innovation, clinical validation, and commercialization strategies, while benefiting from scalable production.

Rising Demand for Advanced Cardiac Care to Propel Cardiovascular Devices Segment GrowthBased on device type, the market is split into cardiovascular, orthopedic, drug delivery, diagnostic imaging, respiratory, and others. The cardiovascular devices segment leads market growth owing to high demand for advanced cardiac care solutions, such as stents, catheters, and monitoring systems, that require precision engineering and strict quality control.

Geographically, the market is studied across North America, Europe, Asia Pacific, and the Rest of the World.

Source: https://www.fortunebusinessinsights.com/medical-device-contract-manufacturing-market-111763

Report CoverageThe report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

Drivers & RestraintsIncreasing Outsourcing by Medical Device Companies to Propel Market GrowthThe rapid growth in outsourcing by medical device companies has raised the demand for contract manufacturing as OEMs seek to reduce capital expenditure, access specialized expertise, and accelerate product commercialization. Complex regulatory requirements and quality standards encourage partnerships with experienced manufacturers, boosting the medical device contract manufacturing market growth.

However, the high dependency on strict regulatory compliance and quality assurance processes, which increases operational complexity and cost, may hamper market growth. Maintaining compliance across multiple jurisdictions can slow the onboarding of new clients and requires continuous investment in documentation, validation, and audits.

Regional InsightsStrong Concentration of Medical Device OEMs in the U.S. Propels Market Growth in North AmericaNorth America holds the dominant medical device contract manufacturing market share and is projected to experience growth during the forecast period. The region’s growth is attributed to the high concentration of medical device OEMs, advanced healthcare systems, and stringent regulatory frameworks, which encourage the outsourcing of complex device production.

Asia Pacific is one of the fastest-growing regions in the market. The growth is attributed to the rapid increase in healthcare demand, cost advantages, and expanding manufacturing capabilities in developing nations, including China and India.

Medical Device Contract Manufacturing Market Future Growth:The medical device contract manufacturing market is experiencing robust growth, fueled by increasing outsourcing by OEMs, the growing complexity of medical devices, and a strong shift toward end-to-end manufacturing partnerships. Today's OEMs are increasingly drawn to partners with advanced automation, cleanroom capacity, and digital quality systems. Additionally, there's a growing interest in specialized capabilities for cardiovascular, orthopedic, and drug delivery devices. The rapid expansion of e-commerce and investment in supply chain resilience are also key growth drivers. While North America continues to dominate the high-complexity segment, the Asia-Pacific region is seeing a surge in demand, driven by cost efficiency and expanding local manufacturing ecosystems.

Competitive LandscapeGrowing Adoption of Mergers and Acquisitions Strategies to Propel Market GrowthThe market features prominent players like Jabil Inc., Integer Holdings Corporation, and others. These leading companies are accelerating growth through strategic initiatives such as mergers and acquisitions to add capabilities, innovative service development, expansion of cleanroom capacity, and investment in digital traceability. Their proactive approach to adapting and evolving with OEM demands continues to fuel the market’s momentum.

Key Industry Development

• February 2025: West Pharmaceutical Services, Inc. launched an expanded service portfolio for combination products, catering to the increasing demand from pharmaceutical and biopharmaceutical partners for integrated device manufacturing.

• October 2024: Jabil Inc. announced a strategic acquisition to strengthen its capabilities in electronics integration and micro-molding, addressing the growing complexity of next-generation medical devices.